TELEPROM Psoriasis: Enhancing patient-centered care and health-related quality of life (HRQoL) in moderate-to-severe plaque psoriasis.

Journal: Frontiers in medicine
Published Date: Dec 10, 2024

Abstract

BACKGROUND AND PURPOSE: Psoriasis is a chronic, immune-mediated inflammatory skin disease that significantly impacts patients' quality of life. The integration of telepharmacy has the potential to enhance patient care by providing flexible and personalized pharmaceutical follow-up. This study (TELEPROM Psoriasis) evaluates a telepharmacy model for evaluating electronic Patient-Reported outcomes (ePROMs) for individuals with moderate to severe plaque psoriasis in Spain with biological treatment.

Authors

  • Gabriel Mercadal-Orfila
    Servicio de Farmacia, Hospital Mateu Orfila, Maó, Spain.
  • Piedad López Sánchez
    Servicio de Farmacia, Hospital General de Tomelloso, Tomelloso, Spain.
  • Aranzazu Pou Alonso
    Servicio de Farmacia, Hospital Universitario de Fuenlabrada, Madrid, Spain.
  • Olatz Ibarra-Barrueta
    Servicio de Farmacia, Hospital Universitario de Galdakao - Usansolo, Bizkaia, Spain.
  • Emilio Monte-Boquet
    Servicio de Farmacia, Hospital Universitario y Politécnico La Fe, Valencia, Spain.
  • Joaquin Borrás Blasco
    Servicio de Farmacia, Hospital de Sagunto, Valencia, Spain.
  • Nuria Padullés Zamora
    Servicio de Farmacia, Hospital Universitario de Bellvitge, Barcelona, Spain.
  • Patricia Sanmartin-Fenollera
    Servicio de Farmacia, Hospital Universitario Fundación Alcorcón, Madrid, Spain.
  • Cristina Capilla Montes
    Servicio de Farmacia, Hospital Universitario del Sureste -Madrid, Madrid, Spain.
  • M Ángeles Bernabéu Martínez
    Servicio de Farmacia, Hospital San Juan-Alicante, Alicante, Spain.
  • Salvador Herrera-Pérez
    Facultad de Ciencias de la Salud, Universidad Internacional de Valencia, Valencia, Spain.

Keywords

No keywords available for this article.

External Resources

Popular Topics
Recent Journals